Previous Article | Next Article ![]()
Infect. Immun., May 1995, 1806-1809, Vol 63, No. 5
E Blasi, L Pitzurra, M Puliti, AR Chimienti, R Mazzolla, R Barluzzi and F Bistoni
Candida albicans is a dimorphic fungus capable of transition from the yeast
form (Y-Candida) to the hyphal form (H-Candida). Both Y-Candida and
H-Candida are known to be growth inhibited by murine macrophages (M phi) in
vitro. In the present report, we demonstrate that M phi exposed to
interferon gamma (IFN-gamma) plus lipopolysaccharide (LPS) show enhanced
anti-Y-Candida and anti-H-Candida activities. To further investigate the
phenomenon, Y-Candida and H-Candida were assessed for susceptibilities to M
phi-derived supernatants. Only the growth of H- Candida, and not that of
Y-Candida, is impaired by cell-free supernatants from M phi treated with
IFN-gamma plus LPS. In contrast, no H-Candida growth inhibition occurs when
supernatants from M phi exposed to IFN-gamma plus LPS in the presence of
NG-monomethyl-L- arginine, an inhibitor of nitric oxide (NO) synthesis, are
employed. Finally, supernatants from M phi incubated with sodium
nitroprusside, an NO-generating agent, also show anti-H-Candida activity.
In conclusion, these results indicate that H-Candida but not Y-Candida is
susceptible to extracellular antifungal mechanisms employed by M phi, which
likely involve stable nitrogen-containing compounds.
Copyright © 1995, American Society for Microbiology
Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds
Department of Biomedical Sciences, University of Modena, Italy.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|